Wells Fargo & Company »

Dyne Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $173k 13k 13.30
2023-09-30 $316k 35k 8.96
2023-06-30 $409k 36k 11.25
2022-09-30 $999 41 24.39
2022-06-30 $2.0k 356 5.62
2022-03-31 $13k 1.4k 9.47
2021-12-31 $144k 12k 11.93
2021-06-30 $7.0k 323 21.67
2021-03-31 $78k 5.0k 15.45
2020-12-31 $155k 7.4k 20.98